- Home
- WGSWW vs SHEL Comparison
WGSWW vs SHEL Comparison
Compare WGSWW & SHEL Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- WGSWW
- SHEL
- Stock Information
- Founded
- WGSWW 2017
- SHEL 1907
- Country
- WGSWW United States
- SHEL United Kingdom
- Employees
- WGSWW 1000
- SHEL N/A
- Industry
- WGSWW Retail: Computer Software & Peripheral Equipment
- SHEL Oil & Gas Production
- Sector
- WGSWW Technology
- SHEL Energy
- Exchange
- WGSWW Nasdaq
- SHEL Nasdaq
- Market Cap
- WGSWW N/A
- SHEL N/A
- IPO Year
- WGSWW N/A
- SHEL N/A
- Fundamental
- Price
- WGSWW $0.03
- SHEL $72.40
- Analyst Decision
- WGSWW
- SHEL Buy
- Analyst Count
- WGSWW 0
- SHEL 6
- Target Price
- WGSWW N/A
- SHEL $77.16
- AVG Volume (30 Days)
- WGSWW 36.6K
- SHEL 3.9M
- Earning Date
- WGSWW 02-18-2025
- SHEL 07-31-2025
- Dividend Yield
- WGSWW N/A
- SHEL 3.96%
- EPS Growth
- WGSWW N/A
- SHEL N/A
- EPS
- WGSWW N/A
- SHEL 2.17
- Revenue
- WGSWW $305,450,000.00
- SHEL $281,069,000,000.00
- Revenue This Year
- WGSWW N/A
- SHEL $1.95
- Revenue Next Year
- WGSWW N/A
- SHEL $0.48
- P/E Ratio
- WGSWW N/A
- SHEL $15.84
- Revenue Growth
- WGSWW 50.79
- SHEL N/A
- 52 Week Low
- WGSWW $0.17
- SHEL $58.55
- 52 Week High
- WGSWW $0.21
- SHEL $74.46
- Technical
- Relative Strength Index (RSI)
- WGSWW N/A
- SHEL 69.50
- Support Level
- WGSWW N/A
- SHEL $71.79
- Resistance Level
- WGSWW N/A
- SHEL $72.72
- Average True Range (ATR)
- WGSWW 0.00
- SHEL 0.88
- MACD
- WGSWW 0.00
- SHEL 0.39
- Stochastic Oscillator
- WGSWW 0.00
- SHEL 91.03
About WGSWW GeneDx Holdings Corp.
GeneDx Holdings Corp delivers personalized and actionable health insights to inform diagnosis, direct treatment and improve drug discovery. The company is uniquely positioned to accelerate the use of genomic and large-scale clinical information to enable precision medicine as the standard of care. The company is at the forefront of transforming healthcare through its various exome and genome testing and interpretation, fueled by one of the world's substantial rare disease data sets.